Try our Advanced Search for more refined results

Expert Analysis

What To Expect After FDA Warnings To GLP-1 Compounders

By Beth Siemer and Kaleb Rasmussen ( October 10, 2025, 6:22 PM EDT) -- As part of a larger crackdown on direct-to-consumer prescription drug advertising, the U.S. Food and Drug Administration published over 55 warning letters on Sept. 16 to online sellers of compounded versions of the popular GLP-1 medications for Type 2 diabetes and weight loss....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies